Journal of Practical Hepatology ›› 2023, Vol. 26 ›› Issue (1): 136-139.doi: 10.3969/j.issn.1672-5069.2023.01.035
Previous Articles Next Articles
Zhang Wei, Hou Wei, Liu Hui, et al
Received:
2022-07-20
Online:
2023-01-10
Published:
2023-02-07
Zhang Wei, Hou Wei, Liu Hui, et al. Recurrence three years after liver transplantation of patients with idiopathic portal hypertension: A case report and literature review[J]. Journal of Practical Hepatology, 2023, 26(1): 136-139.
[1] Khanna R, Sarin SK. Noncirrhotic portal hypertension: current and emerging perspectives. Clin Liver Dis, 2019, 23(4):781-807. [2] De Gottardi A, Rautou PE, Schouten J, et al. Porto-sinusoidal vascular disease: proposal and description of a novel entity. Lancet Gastroenterol Hepatol, 2019, 4(5):399-411. [3] Harmanci O, Bayraktar Y. Clinical characteristics of idiopathic portal hypertension. World J Gastroenterol, 2007, 13(13):1906-1911. [4] Dumortier J, Bizollon T, Scoazec JY, et al. Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome. Scand J Gastroenterol, 2001, 36(4):417-422. [5] McDonald JA, Painter DM, Gallagher ND, et al. Nodular regenerative hyperplasia mimicking cirrhosis of the liver. Gut, 1990, 31(6):725-727. [6] Le Bail B, Bioulac-Sage P, Arnoux R, et al. Late recurrence of a hepatocellular carcinoma in a patient with incomplete alagille syndrome. Gastroenterology, 1990, 99(5):1514-1516. [7] de Sousa JM, Portmann B, Williams R. Nodular regenerative hyperplasia of the liver and the budd-chiari syndrome. case report, review of the literature and reappraisal of pathogenesis. J Hepatol, 1991, 12(1):28-35. [8] Elariny HA, Mizrahi SS, Hayes DH, et al. Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation. Transpl Int, 1994, 7(4):309-313. [9] Bernard PH, Le Bail B, Cransac M, et al. Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol, 1995, 22(4):495-499. [10] Petrowsky H, Allers C, Herrmann G, et al. Liver transplantation and splenectomy in idiopathic portal hypertension. Z Gastroenterol, 1997, 35(5):331-336. [11] Loinaz C, Colina F, Musella M, et al. Orthotopic liver transplantation in 4 patients with portal hypertension and non-cirrhotic nodular liver. Hepato-gastroenterology, 1998, 45(23):1787-1794. [12] Radomski JS, Chojnacki KA, Moritz MJ, et al. Results of liver transplantation for nodular regenerative hyperplasia. Am Surg, 2000, 66(11):1067-1070. [13] Jawaid Q, Saeed ZA, Di Bisceglie AM, et al. Biliary-venous fistula complicating transjugular intrahepatic portosystemic shunt presenting with recurrent bacteremia, jaundice, anemia and fever. Am J Transplant, 2003, 3(12):1604-1607. [14] Buchel O, Roskams T, Van Damme B, et al. Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia. Gut, 2005, 54(7):1021-1023. [15] Krasinskas AM, Eghtesad B, Kamath PS, et al. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl, 2005, 11(6):627-634, discussion 610-621. [16] Tateo M, Sebagh M, Bralet MP, et al. A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients. Liver Transpl, 2008, 14(8):1194-1198. [17] Inokuma T, Eguchi S, Tomonaga T, et al. Acute deterioration of idiopathic portal hypertension requiring living donor liver transplantation: a case report. Dig Dis Sci, 2009, 54(7):1597-1601. [18] Saigal S, Nayak NC, Jain D, et al. Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients. Hepatol Int, 2011, 5(4):882-889. [19] Maganty K, Ghanta R, Bejarano P, et al. Liver transplantation for hepatopulmonary syndrome due to noncirrhotic portal hypertension. Transplant Proc, 2011, 43(7):2814-2816. [20] Schouten JN, Nevens F, Hansen B, et al. Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study. Aliment Pharmacol Ther, 2012, 35(12):1424-1433. [21] Casey S, Schelleman A, Angus P. Recurrence of hepatopulmonary syndrome post-orthotopic liver transplantation in a patient with noncirrhotic portal hypertension. Hepatology, 2013, 58(6):2205-2206. [22] Sultanik P, Coilly A, Sebagh M, et al. Lengthy follow-up after liver transplantation for nodular regenerative hyperplasia in human immunodeficiency virus-infected patients: does the disease recur? Transplantation, 2013, 96(11):e79-81. [23] Matsumoto Y, Ikegami T, Morita K, et al. Renoportal anastomosis in right lobe living donor liver transplantation: report of a case. Surg Today, 2013, 43(11):1316-1320. [24] Meijer B, Simsek M, Blokzijl H, et al. Nodular regenerative hyperplasia rarely leads to liver transplantation: a 20-year cohort study in all dutch liver transplant units. United Eur gastroenterol J, 2017, 5(5):658-667. [25] Kawachi S, Chiba N, Nakagawa M, et al. Living donor liver transplantation for idiopathic portal hypertension with extrahepatic portal vein stenosis and splenic artery aneurysms: a case report and review of the literature. BMC Surg, 2020, 20(1):257. [26] 马博,张雨,张晓雪,等.特发性门静脉高压症肝移植1例报告.临床肝胆病杂志,2020,10(36):2280-2290. [27] Furuichi Y, Moriyasu F, Taira J, et al. Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by arfi elastography. J Gastroenterol, 2013, 48(9):1061-1068. [28] 周慧,冯晓宁,任浩,等.非肝硬化门脉高压患者临床特点分析.实用肝脏病杂志,2021,24(3):415-418. [29] Okuda K, Kono K, Ohnishi K,et al. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology, 1984, 86(4):600-610. [30] Hübscher SG. What is the long-term outcome of the liver allograft? J Hepatol, 2011, 55(3):702-717. [31] Devarbhavi H, Abraham S, Kamath PS. Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation. Liver Transplant, 2007, 13(11):1552-1556. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||